Anita Bakrania

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (14)

• Nanomedicine in hepatocellular carcinoma: A new frontier in targeted cancer treatment
  Pharmaceutics 2022 DOI: 10.3390/pharmaceutics14010041
  +Save
• Antidiabetic potential of gallic acid from Emblica officinalis: Improved glucose transporters and insulin sensitivity through PPAR-γ and Akt signaling
  Bhavesh C. Variya, Anita K. Bakrania, Snehal Sanjay Patel
  Phytomedicine 2020 DOI: 10.1016/j.phymed.2019.152906
  +Save
• Upregulation of pace4 in prostate cancer is not dependent on e2f transcription factors
  Canadian Journal of Physiology and Pharmacology 2020 DOI: 10.1139/cjpp-2019-0668
  +Save
• Acute and 28-days repeated dose sub-acute toxicity study of gallic acid in albino mice
  Bhavesh C. Variya, Anita K. Bakrania, Prem Madan +1 more
  Regulatory Toxicology and Pharmacology 2019 DOI: 10.1016/j.yrtph.2018.11.010
  +Save
• DEAE-Dextran coated paclitaxel nanoparticles act as multifunctional nano system for intranuclear delivery to triple negative breast cancer through VEGF and NOTCH1 inhibition
  Anita K. Bakrania, Bhavesh C. Variya, Lalaji V. Rathod +1 more
  European Journal of Pharmaceutics and Biopharmaceutics 2018 DOI: 10.1016/j.ejpb.2017.10.007
  +Save
• Suppression of abdominal fat and anti-hyperlipidemic potential of Emblica officinalis: Upregulation of PPARs and identification of active moiety
  Bhavesh C. Variya, Anita K. Bakrania, Yuanli Chen +2 more
  Biomedicine and Pharmacotherapy 2018 DOI: 10.1016/j.biopha.2018.09.158
  +Save
• Antitumor potential of herbomineral formulation against breast cancer: Involvement of inflammation and oxidative stress
  Indian Journal of Experimental Biology 2017
  +Save
• Repeated dose 28-day oral toxicity study of DEAE-Dextran in mice: An advancement in safety chemotherapeutics
  Anita K. Bakrania, Bhavesh C. Variya, Prem Madan +1 more
  Regulatory Toxicology and Pharmacology 2017 DOI: 10.1016/j.yrtph.2017.07.005
  +Save
• Role of β-interferon inducer (DEAE-Dextran) in tumorigenesis by VEGF and NOTCH1 inhibition along with apoptosis induction
  Anita K. Bakrania, Bhavesh C. Variya, Snehal Sanjay Patel
  Frontiers in Pharmacology 2017 DOI: 10.3389/fphar.2017.00930
  +Save
• DMBA-induced breast cancer: A hormonal camouflage
  Anita K. Bakrania, Bhavesh C. Variya, Snehal Sanjay Patel
  Current Cancer Therapy Reviews 2016 DOI: 10.2174/1573394713666170316124720
  +Save
• Emblica officinalis (Amla): A review for its phytochemistry, ethnomedicinal uses and medicinal potentials with respect to molecular mechanisms
  Bhavesh C. Variya, Anita K. Bakrania, Snehal Sanjay Patel
  Pharmacological Research 2016 DOI: 10.1016/j.phrs.2016.06.013
  +Save
• Novel targets for paclitaxel nano formulations: Hopes and hypes in triple negative breast cancer
  Anita K. Bakrania, Bhavesh C. Variya, Snehal Sanjay Patel
  Pharmacological Research 2016 DOI: 10.1016/j.phrs.2016.07.023
  +Save
• Pharmacological evaluation of Jambrushila Tablet on animal model of type-2 diabetes
  Bhavesh C. Variya, Anita K. Bakrania, Prabodh V. Shah +1 more
  Natural Products Journal 2016 DOI: 10.2174/221031550601160208194131
  +Save
• Combination treatment for allergic conjunctivitis - Plant derived histidine decarboxylase inhibitor and H1 antihistaminic drug
  Experimental Eye Research 2015 DOI: 10.1016/j.exer.2015.05.020
  +Save